Gasparini G - Search Results

1

Surgical and adjuvant radiation therapy of resectable retroperitoneal soft tissue sarcomas in adults.

Testolin A, Pozza F, Dal Fior S, Bolzicco GP, Panizzoni GA, Gasparini G. Testolin A, et al. Among authors: gasparini g. Tumori. 1992 Dec 31;78(6):388-91. doi: 10.1177/030089169207800609. Tumori. 1992. PMID: 1297234

2

Synchronous radiotherapy and chemotherapy with cisplatin in the management of locally advanced or recurrent head and neck cancer.

Gasparini G, Recher G, Testolin A, Dal Fior S, Panizzoni GA, Cristoferi V, Squaquara R, Pozza F. Gasparini G, et al. Am J Clin Oncol. 1992 Jun;15(3):242-9. doi: 10.1097/00000421-199206000-00013. Am J Clin Oncol. 1992. PMID: 1590279 Clinical Trial.

3

Conservative surgery and irradiation (QUART) in the treatment of 243 stage I-II breast cancer patients.

Gasparini G, Panizzoni GA, Dal Fior S, Germani B, Dall'Antonia F, Segato G, Meli S, Pozza F. Gasparini G, et al. Anticancer Res. 1991 Jul-Aug;11(4):1635-40. Anticancer Res. 1991. PMID: 1746920

4

Simultaneous cis-platinum and radiotherapy in inoperable or locally advanced squamous cell carcinoma of the head and neck.

Gasparini G, Pozza F, Recher G, Panizzoni GA, Cristoferi V, Squaquara R, Dal Fior S. Gasparini G, et al. Oncology. 1991;48(4):270-6. doi: 10.1159/000226941. Oncology. 1991. PMID: 1891167

5

Radiotherapeutic treatment for breast cancer choroidal metastases.

Panizzoni GA, Gasparini G, Dal Fior S, Pinna V, Marchetti C, Pozza F. Panizzoni GA, et al. Among authors: gasparini g. Tumori. 1990 Dec 31;76(6):563-5. doi: 10.1177/030089169007600610. Tumori. 1990. PMID: 2284693 Review.

6

Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features.

Gasparini G, Gullick WJ, Bevilacqua P, Sainsbury JR, Meli S, Boracchi P, Testolin A, La Malfa G, Pozza F. Gasparini G, et al. J Clin Oncol. 1992 May;10(5):686-95. doi: 10.1200/JCO.1992.10.5.686. J Clin Oncol. 1992. PMID: 1349034

7

Peritumoral lymphatic vessel invasion compared with DNA ploidy, proliferative activity, and other pathologic features as prognostic indicators in operable breast cancer.

Gasparini G, Meli S, Panizzoni GA, Visonà A, Boracchi P, Bevilacqua P, Marubini E, Pozza F. Gasparini G, et al. Breast Cancer Res Treat. 1992 Mar;20(3):195-204. doi: 10.1007/BF01834625. Breast Cancer Res Treat. 1992. PMID: 1571572

8

Osteosarcoma of the facial bones.

Panizzoni GA, Gasparini G, Clauser L, Barasti P, Pozza F, Curioni C. Panizzoni GA, et al. Among authors: gasparini g. Ann Oncol. 1992 Apr;3 Suppl 2:S47-50. doi: 10.1093/annonc/3.suppl_2.s47. Ann Oncol. 1992. PMID: 1622865 Free article.

9

Phase I study of escalating dose mitoxantrone in combination with alpha-2-interferon in patients with advanced solid tumors.

Gasparini G, Dal Fior S, Pozza F, Panizzoni GA, Favretto S, Von Hoff DD. Gasparini G, et al. Invest New Drugs. 1991 Aug;9(3):245-52. doi: 10.1007/BF00176977. Invest New Drugs. 1991. PMID: 1783524 Clinical Trial.

10

Weekly epirubicin versus doxorubicin as second line therapy in advanced breast cancer. A randomized clinical trial.

Gasparini G, Dal Fior S, Panizzoni GA, Favretto S, Pozza F. Gasparini G, et al. Am J Clin Oncol. 1991 Feb;14(1):38-44. doi: 10.1097/00000421-199102000-00009. Am J Clin Oncol. 1991. PMID: 1987737 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

895 results

Search Page

Filters